Comparative Clinical Evaluation Of Processed Triphala in the Management of Dyslipidemia
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Evaluation of the efficacy of this intervention on serum Lipid levels, Body weight, Body Mass Index (BMI), and Fasting Blood Glucose, will be evaluated before treatment and on the 15th, 30th day and 45th day during the treatment. Changes in subjective criteria like Palpitation, exertional dyspnea, fatigue, corneal arcus, and xanthelasma will also be interrogated and recorded before treatment and after completion of the intervention. Conclusions were drawn. using appropriate statistical techniques.
研究概览
简要总结
According to Ayurveda Dyslipidemia can be correlated under Medoroga or Medodushti. The aetiology of Dyslipidemia, to a great extent, is like the Nidana of Medodushti. The increase in Medodhatu due to Medodhatwagni mandya and vitiated Medodhatu led to Srotoavarrodha and Vata Prakopa, which impairs the Dhatuparinam process a condition that arises due to medovridhi which in turn restricts the nourishment of other dhatus. This study aims the effect of processed Bavitha Triphala in the management of Dyslipidemia. The study will be conducted as a comparative clinical trial. The subjects will be selected based on the detailed clinical proforma and according to inclusion criteria from the Out Patient Department of Mannam Ayurveda Co-operative Medical College Pandalam, Kerala
| Particulars |
Group A
Group B
|Sample size
100
100
|Drug
Processed Triphala
Navagulggulu
|Form
Powder
Tablet
|Dose
10gm (5gm twice daily)
2 Nos (1 tab twice a day)
|Anupana
Honey
Luke warm water
|Duration
45 Days
45 Days
Evaluation of the efficacy of this intervention on serum Lipid levels, Body weight, Body Mass Index (BMI), and Fasting Blood Glucose, will be evaluated before treatment and on the 15th, 30th day and 45th day during the treatment. Changes in subjective criteria like Palpitation, exertional dyspnea, fatigue, corneal arcus, and xanthelasma will also be interrogated and recorded before treatment and after completion of the intervention. Conclusions were drawn. using appropriate statistical techniques.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of both sexes having any one or all of the following altered lipid levels will be selected. (ATP III Guidelines, NCEP) Total cholesterol above 200mg/ di LDL cholesterol above 130mg/di HDL cholesterol below 40 mg/di Triglycerides above 150mg/di Age group-
- •70 years Patients are informed of the given written consent.
排除标准
- •Patients in the age group below 30 years and above 70 years.
- •Patients having serious Cardiac disorders like MI and cardiac failure.
- •Pregnant and lactating women.
- •Severe hepatic disorders.
- •The patient has a history of untreated thyroid disorders.
- •Uncontrolled Diabetes mellitus Known case of any type of Malignancy, Renal insufficiency.
结局指标
主要结局
Evaluation of the efficacy of this intervention on serum Lipid levels, Body weight, Body Mass Index (BMI), and Fasting Blood Glucose, will be evaluated before treatment and on the 15th, 30th day and 45th day during the treatment. Changes in subjective criteria like Palpitation, exertional dyspnea, fatigue, corneal arcus, and xanthelasma will also be interrogated and recorded before treatment and after completion of the intervention. Conclusions were drawn. using appropriate statistical techniques.
时间窗: 15th, 30th day and 45thday -DURING THE TREATMENT
次要结局
- ASSES THE COMPARATIVE EFFICACY BETWEEN PROCESSED TRIPHALA AND NAVAGULGULU IN DYSLIPIDEMIA(FOLLOW UP-3 MONTHS)
研究者
DR ARYA PRABHU
MANNAM AYURVEDA COOPERATIVE MEDICAL COLLEGE